Sage Capital Advisors »

Vertex Pharmaceuticals Incorporated shares owned by Sage Capital Advisors

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Sage Capital Advisors from 13F filings

Historical chart of Sage Capital Advisors investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Sage Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Sage Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $219k 523 417.97
2023-12-31 $213k 523 406.85

More positions owned by Sage Capital Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Qualcomm (QCOM)
Raytheon Technologies Corp (RTX)
FedEx Corporation (FDX)
Home Depot (HD)
Select Sector Spdr Tr Technology (XLK)
Westrock (WRK)
Pepsi (PEP)
Johnson & Johnson (JNJ)
Costco Wholesale Corporation (COST)

View all positions for Sage Capital Advisors

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
Alliancebernstein
T. Rowe Price Associates
Jpmorgan Chase & Co
Wellington Management Company
Jennison Associates
Massachusetts Financial Services
Norges Bank Investment Management
Amundi
Bank of America Corporation
Ubs Global Asset Management Americas
ClearBridge Advisors
Legal & General Group
Henderson Group
Bank of New York Mellon

View all funds holding Vertex Pharmaceuticals Incorporated